Laboratories comparing [retatrutide](/product/glp-3-rt-10mg) vs [semaglutide](/product/semaglutide-30mg) are usually trying to stop a purchasing error: two incretin-class research names on one requisition, two different vials in the fridge, and a COA that will not match if the SKUs are swapped. This guide is a catalog and documentation map for UAE in vitro work. It is not a clinical ranking.
VaultLabs lists retatrutide research material as GLP-3 RT 10mg and GLP-3 RT 20mg. Semaglutide research material is a separate line at semaglutide 30mg. If a purchase order says “GLP peptide” without a catalog name, stop and name the SKU before anyone signs receiving.
What each name actually refers to
Retatrutide, in the published research literature, is a triple-agonist peptide studied in metabolic pathway models. On this site the owner page for that identity is the retatrutide compound monograph. The commercial UAE landing that answers “can we buy it here, with a COA, in AED” is retatrutide research peptide UAE.
Semaglutide is a different sequence. The owner page for supply context is semaglutide research peptide UAE. Do not collapse the two names into “the GLP vial.” They are not aliases.
A useful receiving rule: the printed catalog name on the vial is the identity you inventory. Literature names belong in the ELN crosswalk, not on the fridge label, until that crosswalk is written down.
Why labs mix the two names
Three mix-ups show up on UAE purchase orders:
- A requester copies a paper title that uses the INN (retatrutide or semaglutide) while the catalog only prints GLP-3 RT or the semaglutide SKU string.
- A finance line is reused from an older GLP-class order and the strength field is left as “10mg” without checking which compound the 10 mg refers to.
- A quote comparison uses purity percentages as if they ranked the two materials. Purity is a lot result under one method. It is not a reason to substitute SKUs.
If your team only needs one of these materials, send them to the owner page for that compound. This article exists so the comparison query does not pull traffic away from those pages with a third, thinner overview.
Documentation that must stay distinct
Before either vial is released from quarantine, match four strings:
- Catalog SKU on the invoice (GLP-3 RT 10mg, GLP-3 RT 20mg, or semaglutide 30mg).
- Printed name and nominal mass on the vial.
- Lot / batch identifier on the vial and on the COA.
- Sequence or identity field on the COA, when the supplier prints one.
A COA that is analytically excellent for the wrong identity is still a failed receipt. How to read a peptide COA covers the field-by-field check. Interpreting assay results covers what the numbers mean after the names already match.
Format and strength are not a quality ranking
VaultLabs currently offers retatrutide research presentations at 10 mg and 20 mg lyophilized, and semaglutide research material at 30 mg lyophilized. Those numbers are nominal catalog mass, not a statement that one compound is “stronger” or more suitable for a study.
Choose the SKU your protocol’s stock-solution math was written for. If the protocol was written against a 10 mg vial and someone substitutes a 20 mg vial “because it is the same peptide,” the concentration arithmetic changes. Use the peptide reconstitution calculator to check mass-and-volume math after the identity is locked. The calculator does not design a study.
UAE receiving notes that apply to both SKUs
Gulf summer heat is the usual integrity risk, not a missing freezer brand. Move the parcel out of ambient as soon as it is signed for. Log lot, SKU, and time of receipt. Then file the lot in batch verification.
Storage for sealed lyophilized vials follows the printed label. The general owner page for temperature decisions is the research peptide storage guide. If you are choosing between fridge and freezer as a site policy, use freezer vs refrigerator storage.
Invoicing is in AED. Research-use acknowledgements sit on the research use policy. Neither compound is supplied for human or animal consumption.
A short qualification checklist
- Write the catalog SKU on the requisition, not “GLP” or “reta/sema.”
- Refuse a substitution that changes identity even if the purity number looks higher.
- Match vial lot to the published COA before the vial enters a validated workflow.
- Keep retatrutide and semaglutide on separate inventory rows.
- Link the ELN entry to the compound monograph, not to a blog title.
What this page will not do
It will not tell you which compound to study. It will not interpret literature efficacy. It will not provide preparation steps for anything other than laboratory documentation. If you need the retatrutide buying and documentation path, open retatrutide research peptide UAE. If you need the semaglutide path, open semaglutide research peptide UAE.
VaultLabs materials remain in vitro research reagents.
